Sodium Acetate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Sodium Acetate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 3, 2016.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-3299-06
Dosage Form
Injection
Presentation
Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)
Initial Posting
Feb 3, 2016

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.